Search Results - "Nagakawa, Osamu"

Changes in blood pressure and arterial stiffness monitored using the cardio-ankle vascular index during hemodialysis by Sato, Shuji, Shimizu, Kazuhiro, Takahashi, Mao, Masai, Motoyuki, Nagakawa, Osamu, Uchino, Junji, Suzuki, Toshihiro, Sato, Yuka, Iwai, Noriko, Shirai, Kohji

“…During hemodialysis (HD), blood pressure (BP) changes are frequently observed. However, the mechanism of BP changes during HD has not been fully clarified. The…”
Get full text

Occult Hepatitis B Virus Infection in Japanese Chronic Hemodialysis Patients by Nagakawa, Osamu, Miyatomi, Yoshiho, Shigeta, Yasuhiro, Inayama, Emi, Murakami, Kouichi, Sakai, Takehiko, Kouno, Takashi, Masai, Motoyuki, Shirai, Kohji, Yoshida, Toyohiko

“…We investigated the prevalence of occult hepatitis B virus (HBV) infection in Japanese chronic hemodialysis patients. Hemodialysis patients (n = 1041) were…”
Get full text

Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer by Yasuda, Kenji, Nagakawa, Osamu, Akashi, Takuya, Fujiuchi, Yasuyoshi, Koizumi, Keiichi, Komiya, Akira, Saiki, Ikuo, Fuse, Hideki

“…BACKGROUND Hepatocyte growth factor (HGF) is secreted as an inactive single‐chain precursor called pro‐HGF. Pro‐HGF is converted to an active two‐chain form by…”
Get full text

Importance of Isolated Anti-HBc in Detection of Occult Hepatitis B Virus Infection in Hemodialysis Patients: Reply by Nagakawa, Osamu, Miyatomi, Yoshiho, Shigeta, Yasuhiro, Inayama, Emi, Murakami, Kouichi, Sakai, Takehiko, Kouno, Takashi, Masai, Motoyuki, Shirai, Kohji, Yoshida, Toyohiko

Get full text

P5.32: Waon-Therapy (Warming Therapy) Improved Cardiac Function Associating with Decreasing Cardio-Ankle Vascular Index (Cavi) in Heart Failure Patients by Shirai, Kohji, Osamu, Nagakawa, Keiichi, Hirano, Hirohumi, Noike, Mao, Takahashi, Kazuhiro, Shimizu, Toyohiko, Yoshida

“…Objects Waon-Therapy was invented for the therapy of heart failure by Dr. Tei. The purpose of this study was to confirm the efficacy of Waon therapy and to…”
Get full text

Serum Hepatocyte Growth Factor Activator (HGFA) in Benign Prostatic Hyperplasia and Prostate Cancer by Nagakawa, Osamu, Yamagishi, Toshiya, Fujiuchi, Yasuyoshi, Junicho, Akira, Akashi, Takuya, Nagaike, Kazuhiro, Fuse, Hideki

“…Hepatocyte growth factor activator (HGFA) is responsible for proteolytic activation of the precursor form of hepatocyte growth factor (HGF). We attempted to…”
Get full text

Prognostic Significance of Serum Soluble Fas Level and Its Change during Regression and Progression of Advanced Prostate Cancer by FURUYA, Yuzo, NAGAKAWA, Osamu, FUSE, Hideki

“…To evaluate the clinical usefulness of serum soluble Fas (sFas) and sFas ligand as a prognostic factor and for monitoring the regression and progression of…”
Get full text

Effect of prostatic neuropeptides on migration of prostate cancer cell lines by Nagakawa, Osamu, Ogasawara, Masaru, Murata, Jun, Fuse, Hideki, Saiki, Ikuo

“…Background: A previous study by the same authors demonstrated that among various neuropeptides in the prostate, calcitonin gene‐related peptide (CGRP) and…”
Get full text

Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines by Nagakawa, Osamu, Murakami, Koji, Yamaura, Takeshi, Fujiuchi, Yasuyoshi, Murata, Jun, Fuse, Hideki, Saiki, Ikuo

“…Membrane-type metalloproteinase-1 (MT1-MMP) is a transmembrane metalloproteinase, which activates proMMP-2 and expressed on the cell surface in many invasive…”
Get full text

Telomerase activity is correlated with lower grade and lower stage bladder carcinomas by OKUMURA, AKIOU, MIZUNO, ICHIRO, NAGAKAWA, OSAMU, FUSE, HIDEKI

“…Background:  Telomerase is a ribonucleoprotein enzyme that compensates for the progressive erosion of telomeres. The increasing interest in telomerase is…”
Get full text

Low Serum Testosterone Level Predicts Worse Response to Endocrine Therapy in Japanese Patients with Metastatic Prostate Cancer by FURUYA, YUZO, NOZAKI, TETSUO, NAGAKAWA, OSAMU, FUSE, HIDEKI

“…Patients with prostate cancer generally respond to androgen withdrawal therapy, but progression to androgen-independence is frequently observed later. To…”
Get full text

Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer by Furuya, Yuzo, Fuse, Hideki, Nagakawa, Osamu, Masai, Motoyuki

“…Serum prostate-specific antigen (PSA) determination has led to the increased detection of nonpalpable prostate cancer (T1c cancer). Some T1c cancers are small…”
Get full text

PS 02-16 CHANGES OF ARTERIAL STIFFNESS MONITORED WITH THE CARDIO-ANKLE VASCULAR INDEX (CAVI) DURING HEMODIALYSIS THERAPY by Sato, Shuji, Shimizu, Kazuhiro, Takahashi, Mao, Nagakawa, Osamu, Shirai, Kohji

Get full text

Modeling Low Muscle Mass Screening in Hemodialysis Patients by Senzaki, Daiki, Yoshioka, Nobuo, Nagakawa, Osamu, Inayama, Emi, Nakagawa, Takafumi, Takayama, Hidehito, Endo, Toko, Nakajima, Fumitaka, Fukui, Masayoshi, Kijima, Yasuaki, Oyama, Yasuo, Kudo, Risshi, Toyama, Tadashi, Yamada, Yosuke, Tsurusaki, Kiyoshi, Aoyama, Naoki, Matsumura, Takayasu, Yamahara, Hideki, Miyasato, Kenro, Kitamura, Tetsuya, Ikenoue, Tatsuyoshi

“…Computed tomography (CT) can accurately measure muscle mass, which is necessary for diagnosing sarcopenia, even in dialysis patients. However, CT-based…”
Get more information

The efficacy of Gosyajinkigan for pollakisuria by Watanabe, Akihiko, Akashi, Takuya, Fujiuchi, Yasuyoshi, Mizuno, Ichiro, Nagakawa, Osamu, Fuse, Hideki

“…We investigated the efficacy of Gosyajinkigan in 20 patients with prostatic disease, in whom pollakisuria was not improved by treatment with drugs for lower…”
Get full text

Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer by Yasuda, Kenji, Komiya, Akira, Watanabe, Akihiko, Morii, Akihiro, Oya, Takeshi, Nagakawa, Osamu, Fujiuchi, Yasuyoshi, Fuse, Hideki

“…Hepatocyte growth factor activator inhibitor type-1 (HAI-1) inhibits hepatocyte growth factor activator and matriptase. In the present study it was…”
Get full text

Low Serum Testosterone Level Predicts Worse Response to Endocrine Therapy in Japanese Patients with Metastatic Prostate Cancer by YUZO FURUYA, TETSUO NOZAKI, OSAMU NAGAKAWA, HIDEKI FUSE

“…Patients with prostate cancer generally respond to androgen withdrawal therapy, but progression to androgen-independence is frequently observed later. To…”
Get full text

O ccult H epatitis B V irus I nfection in J apanese C hronic H emodialysis P atients by Nagakawa, Osamu, Miyatomi, Yoshiho, Shigeta, Yasuhiro, Inayama, Emi, Murakami, Kouichi, Sakai, Takehiko, Kouno, Takashi, Masai, Motoyuki, Shirai, Kohji, Yoshida, Toyohiko

“…We investigated the prevalence of occult hepatitis B virus ( HBV ) infection in J apanese chronic hemodialysis patients. Hemodialysis patients ( n  = 1041)…”
Get full text

Waon-Therapy (warming therapy) improved cardiac function associating with decreasing cardio-ankle vascular index (CAVI) in heart failure patients by Shirai, Kohji, Osamu, Nagakawa, Keiichi, Hirano, Hirohumi, Noike, Mao, Takahashi, Kazuhiro, Shimizu, Toyohiko, Yoshida

Get full text

Androgen receptor negatively influences the expression of chemokine receptors (CXCR4, CCR1) and ligand-mediated migration in prostate cancer DU-145 by AKASHI, Takuya, KOIZUMI, Keiichi, NAGAKAWA, Osamu, FUSE, Hideki, SAIKI, Ikuo

“…We previously reported that androgen receptor (AR) plays a role in the regulation of adhesion to the extracellular matrix and invasion of human prostate cancer…”
Get full text